ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)

SHA:600479 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	308.14	286.29	230.76	320.41	302.51	302.06
Depreciation & Amortization	106.07	106.07	99.65	103.65	95.6	85.93
Other Amortization	17.97	17.97	20.9	18.53	16.8	16.22
Loss (Gain) From Sale of Assets	-1.88	-1.88	-0.5	-	-	-33.54
Asset Writedown & Restructuring Costs	0.6	0.6	4.69	0.94	-0.17	0.43
Loss (Gain) From Sale of Investments	-46.6	-46.6	-16.22	-15.87	-19.65	-26.41
Provision & Write-off of Bad Debts	1.84	1.84	5.61	17.84	2.17	-0.29
Other Operating Activities	96.99	96.13	78.83	79.28	88.17	75.41
Change in Accounts Receivable	-180.78	-180.78	18.73	-8.69	-163.72	275.85
Change in Inventory	-8.47	-8.47	44.61	62.29	-51.22	-52.4
Change in Accounts Payable	244.4	244.4	-147.8	-132.49	465.43	-160.39
Change in Other Net Operating Assets	-35.42	-35.42	60.88	-	-	-
Operating Cash Flow	502.96	480.24	398.77	443.12	733.47	485.57
Operating Cash Flow Growth	13.13%	20.43%	-10.01%	-39.59%	51.05%	-10.47%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-142.98	-124.17	-47.32	-43.99	-34.43	-71.88
Sale of Property, Plant & Equipment	2.22	2.22	0.39	0.06	0.2	30.82
Investment in Securities	-496.01	-813.62	-700	618.4	130.07	-25.18
Other Investing Activities	4.57	4.57	5.75	10.82	26.32	22.9
Investing Cash Flow	-632.2	-931	-741.18	585.29	122.15	-43.34

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	-	-	-	42.15	-	60
Long-Term Debt Repaid	-	-37.08	-69.41	-74.6	-43.83	-149.85
Net Debt Issued (Repaid)	-37.08	-37.08	-69.41	-32.46	-43.83	-89.85
Issuance of Common Stock	2	2	-	0.44	48.59	-
Repurchase of Common Stock	-16.56	-16.56	-16.54	-3.38	-	-
Common Dividends Paid	-152.68	-152.68	-152.82	-147.89	-248.65	-429.53
Other Financing Activities	53.56	55.32	-11.36	-18.72	-20.29	-1.2
Financing Cash Flow	-150.76	-149	-250.12	-202	-264.19	-520.58

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash Flow	-280	-599.75	-592.54	826.4	591.43	-78.35

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	359.98	356.08	351.45	399.13	699.04	413.69
Free Cash Flow Growth	-10.76%	1.32%	-11.95%	-42.90%	68.97%	-7.06%
Free Cash Flow Margin	10.02%	9.81%	9.68%	10.51%	17.36%	11.29%
Free Cash Flow Per Share	0.80	0.83	0.85	0.94	1.63	0.99
Levered Free Cash Flow	364.91	345.46	226.34	241.45	716.2	333.96
Unlevered Free Cash Flow	364.93	345.5	227.04	242.5	717.59	335.28

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	339.61	330.15	347.79	329.57	290.93	319.05
Change in Working Capital	19.83	19.83	-24.94	-81.67	248.05	65.76

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 27, 2026

Data Sources Report a data error